Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | PAB1-binding protein , putative | 0.0029 | 0.0377 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0029 | 0.0377 | 1 |
Brugia malayi | hypothetical protein | 0.0041 | 0.0808 | 0.0808 |
Schistosoma mansoni | hypothetical protein | 0.0194 | 0.6151 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0377 | 0.0377 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0041 | 0.0808 | 0.0808 |
Onchocerca volvulus | 0.0276 | 0.9002 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0185 | 0.5834 | 0.5834 |
Echinococcus multilocularis | jun protein | 0.019 | 0.6017 | 0.6017 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0041 | 0.0808 | 0.1313 |
Entamoeba histolytica | hypothetical protein | 0.0041 | 0.0808 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.019 | 0.6017 | 0.6017 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0029 | 0.0377 | 1 |
Echinococcus multilocularis | geminin | 0.0194 | 0.6151 | 0.6151 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0029 | 0.0377 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0194 | 0.6151 | 1 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0018 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0041 | 0.0808 | 0.5 |
Brugia malayi | Pax transcription factor protein 2 | 0.0276 | 0.9002 | 0.9002 |
Brugia malayi | hypothetical protein | 0.0149 | 0.4589 | 0.4589 |
Loa Loa (eye worm) | zinc finger protein | 0.0304 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0155 | 0.4771 | 0.7757 |
Schistosoma mansoni | jun-related protein | 0.0155 | 0.4771 | 0.7757 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0029 | 0.0377 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0137 | 0.4146 | 0.4146 |
Echinococcus granulosus | geminin | 0.0194 | 0.6151 | 0.6151 |
Brugia malayi | hypothetical protein | 0.0029 | 0.0377 | 0.0377 |
Echinococcus granulosus | zinc finger transcription factor gli2 | 0.0304 | 1 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0137 | 0.4146 | 0.4146 |
Echinococcus multilocularis | zinc finger transcription factor gli2 | 0.0304 | 1 | 1 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0276 | 0.9002 | 0.9002 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.019 | 0.6017 | 0.6017 |
Entamoeba histolytica | hypothetical protein | 0.0041 | 0.0808 | 0.5 |
Echinococcus granulosus | jun protein | 0.019 | 0.6017 | 0.6017 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0019 | 0.0019 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0808 | 0.1313 |
Brugia malayi | bZIP transcription factor family protein | 0.019 | 0.6017 | 0.6017 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0029 | 0.0377 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0029 | 0.0377 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0041 | 0.0808 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0041 | 0.0808 | 0.0808 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0137 | 0.4146 | 0.4146 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0029 | 0.0377 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Delta blood pressure (functional) | 0 mmHg | Difference in systolic blood pressure of SH rats observed prior to the first application and 2 hr after the fifth application was expressed as Delta BP; NT=Not tested | ChEMBL. | 6492077 |
ED25 (functional) | = 10 mg kg-1 | Dose estimated to produce 25 mm Hg fall in mean systemic blood pressure of anesthetized cat at 10 min after administration | ChEMBL. | 6492077 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.